A study looking at the long term follow up of people who have taken aspirin and esomeprazole to help prevent oesophageal cancer (AspECT Excel)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Oesophageal cancer

Status:

Closed

Phase:

Other

Details

This study is looking at the long term benefits and risks of taking aspirin and esomeprazole to help prevent oesophageal cancer. It is a continuation of the AspECT trial.

It is open to people who took part in the AspECT trial.

Cancer Research UK supports this study.

Recruitment start: 6 August 2023

Recruitment end: 14 October 2024

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Janusz Jankowski

Supported by

Cancer Research UK

University College London (UCL)

Other information

This is Cancer Research UK trial number is CRUK/21/020.

Last reviewed: 6 November 2024

CRUK internal database number: 19401

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.